Clinical research

Reading comfort, grounded in clinical research

Le confort de lecture au cœur de la recherche clinique

The Science Behind Lili

What Lili Works On

Reading happens in two steps: the eye and brain first take in the visual shape of a word, then access its meaning. For many dyslexic readers, visual interference appears at the first step: letters seem to overlap, crowd or fade.

Lili's pulsed light works precisely on this visual step: it helps steady the letters so the word reaches the brain more clearly, and reading flows more easily. Drag the slider across the image to see the difference.

Without Lili

With Lili

Drag

From Discovery to Clinical Studies

2017

A Discovery in France

The original research into using pulsed light to support reading for people with dyslexia began in France.

2020

Institutional Recognition

The Académie Nationale de Médecine, founded in 1820, recognized the interest of this research.

2022

First solution on the market

Launch of the portable Lili reading lamp.

2026

Range extension and validation

Launch of the Lili Screen.

Completion of two independent clinical studies conducted with the CNRS and Robert-Debré University Hospital, led by Maria Pia Bucci.

A rigorous scientific protocol

2 complementary clinical studies

Conducted between 2025 and 2026, these two randomised, double-blind clinical studies scientifically measured:

  • The effects of the Lili Lamp on children
  • The effects of the Lili Screen on adults

Clinical study objectives

Led by Maria Pia Bucci's research team (CNRS / Robert-Debré University Hospital), the studies combined several assessment methods:

  • Standardised speech and language assessments
  • In-depth visual-attentional tests
  • Eye-tracking analyses and voice recordings

A demanding double-blind methodology

Because Lili's light pulses are completely invisible to the naked eye, participants do not know whether the technology is switched on or off during the tests. This strict protocol ensures fully impartial results and scientifically rules out any placebo effect.

The study protocols are available on clinical trial registries:
ISRCTN21209189, ISRCTN14080164.

What the studies revealed

Measured with the technology on and off, on the same readers and the same texts.

100% of participants improved

Children and adults: an improvement measured on at least one reading criterion during the tests.

33% fewer reading errors

Adults: a third fewer letter-positioning errors, for clearer reading.

+21% faster reading of common words

Adults: faster, smoother and more instinctive decoding across all the texts tested.

+77% in reading comprehension

Children: direct access to meaning, beyond simple decoding. Comprehension almost doubled.

+24% faster reading of common words

Children: much faster decoding of everyday words, freeing up energy for memorisation.

*Data from clinical studies conducted by a CNRS team at Robert-Debré Hospital with children and adults with dyslexia. Scientific papers are currently being published in a peer-reviewed journal. Every profile is unique, so results may vary from one person to another.

Disclaimer: Lili is a technology designed to optimise reading comfort. It is neither a medical device nor a therapeutic treatment. It was developed to support and complement speech therapy sessions or educational support, and never replaces them.

Our clinical studies are now complete. Their findings are being prepared for official publication in a peer-reviewed scientific journal, expected during 2026.

Find out how our innovation works in detail on the Our technology page, or go straight to the Lili Lamp and the Lili Screen.